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Abstract
Background: Persistent organic pollutants (POPs) are environmentally and biologically persistent chemicals that
include polybrominated diphenyl ethers (PBDEs), per- and polyfluoroalkyl substances (PFASs), polychlorinated
biphenyls (PCBs), and organochlorine (OC) pesticides. Currently, data on the associations between exposure to POPs
and the risk of mortality in the U.S. population is limited.
Our objective was to determine if higher exposure to POPs is associated with greater risk of all-cause, cancer, heart/
cerebrovascular disease, or other-cause mortality.
Methods: Analyses included participants aged 60 years and older from the 1999–2006 National Health and
Nutrition Examination Surveys (NHANES). We included 483 participants for analyses of PBDEs, 1043 for PFASs, and
461 for PCBs, and 1428 for OC pesticides. Exposures to POPs were estimated using biomarkers measured in serum.
Mortality status through December 31, 2011 was obtained from public-use, linked mortality files. We used Cox
proportional hazard models to quantify the associations of interest. Where we observed an association, we explored
effect modification by sex, body mass index, smoking status, and albuminuria. We also explored the combined
effect of PBDEs and OC pesticides in the subsample of participants with measures of both analytes.
Results: Serum measurements of PBDEs, PFASs, and PCBs were not clearly associated with increased all-cause or
cause-specific mortality in older Americans. Beta-hexachlorocyclohexane was associated with an increased risk of all-cause
mortality [HR per 1 SD increase =1.18, 95% CI = 1.01, 1.38]. Oxychlordane [HR = 1.15 95% CI 1.06, 1.25], p,p’-DDE [HR = 1.12,
95% CI = 1.02, 1.23], trans-nonachlor [HR = 1.11, 95% CI = 1.04, 1.18], and beta-hexachlorocyclohexane [HR = 1.25, 95%
CI = 1.03, 1.52] were associated with increased risk of other-cause mortality. Exploratory analyses suggested associations
between OC pesticides and other-cause mortality were modified by sex. Exploratory analyses also suggested that the
combination of high PBDE and high OC pesticide exposure had a stronger than expected adverse effect on all-cause
mortality.
Conclusion: Higher exposure to beta-hexachlorocyclohexane, an OC pesticide, is associated with increased all-cause
mortality and higher exposure to four OC pesticides is associated with increased non-cancer, non-heart/cerebrovascular
disease mortality in U.S. adults 60 years or older. These associations may be modified by sex or exposure to other POPs.
Keywords: Persistent organic pollutants, Mortality, Flame retardants, Organochlorine pesticides, Polybrominated diphenyl
ethers, PBDEs, Per- and polyfluoroalkyl substances, PFASs, Polychlorinated biphenyls, PCBs
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Background
Persistent organic pollutants (POPs) are chemicals that include polybrominated diphenyl ethers (PBDEs), per- and
polyfluoroalkyl substances (PFASs), polychlorinated biphenyls (PCBs), and organochlorine (OC) pesticides. POPs persist environmentally and biologically and often
bioaccumulate [1–5]; thus low-level exposure is widespread
despite cessation or restrictions on manufacture and use,
and POPs continue to be detectable in a large portion of
the U.S population [6, 7]. However, we know relatively little
about the health effects of exposure to these compounds,
including their impact on mortality. Considering the prevalence, persistence, and bioaccumulation of POPs, an association with mortality in the U.S. population would have
significant public health implications.
PBDEs are mixtures of chemicals that have been used
as flame-retardants in many consumer products such as
upholstery, plastics, and cabinets [3, 8]. Exposure to
PBDEs often occur through ingesting contaminated dust,
food, and breastmilk; touching contaminated soil or
commercial products; and inhaling contaminated air [9,
10]. Some studies have suggested that exposure to
PBDEs is associated with changes to neurodevelopment
[11, 12], however, our understanding of the human
health effects due to exposure is limited. To date, we are
unaware of any studies assessing the association between
PBDEs and mortality in the general population.
PFASs consist of a group of manufactured chemicals
that repel water and oil, making them resistant to stains
[4, 13]. Because of this characteristic, PFASs have been
used for consumer products such as cookware, sofas,
carpets, clothing, food packaging, paints, and cleaning
products [4, 13]. Thus, exposure to PFASs can occur
through contact with products treated with PFASs; contact with contaminated water, soil, and outdoor air near
the industrial sites that manufacture or use PFASs; and
consumption of contaminated food [14–17]. As with
PBDEs, questions about the health effects related to exposure of PFASs at the levels that are normally found in
the environment remain. Although existing studies often
report conflicting findings, PFASs have been reported to
increase cholesterol [18, 19] and risk of cancer [20],
affect the immune system [21, 22], and decrease fertility
[23]. However, as with PBDEs, whether nonoccupational exposure to PFASs increases morality risk
is unknown.
PCBs include manufactured mixtures of chlorinated
compounds that were used as lubricants and coolants in
electrical equipment, as well as other industrial applications such as plasticizers and pigments [1, 24]. The production of PCBs in the U.S. ended in 1979 because of
their persistence in the environment and concern about
potential health effects [24] and many countries worldwide eliminated the production and use of PCBs in
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2004, in accordance with the Stockholm Convention
[25]. However, because PCBs persist in the environment
for many years, exposure to PCBs persists through use
of contaminated electronic equipment and consumption
of contaminated soil, air, water, food, and breastmilk [1,
26–28]. Increasing evidence suggests that low-level exposure to PCBs may have adverse health consequences
[29–32] and the Environmental Protection Agency
(EPA) has classified PCBs as probable human carcinogens [24]; however, whether PCB exposure increase risk
of mortality in the general population remains uncertain.
Two prior studies have used NHANES data to analyze
associations of PCBs with mortality in the general population, however, they were limited by relatively short
follow-up times and the omission of considering education or other measures of socioeconomic status as potential confounders [33, 34].
Finally, OC pesticides are a class of pesticides that
were used because of their effectiveness against a wide
variety of insects. OC pesticides that were once in common use include dichlorodiphenyltrichloroethane
(DDT), oxychlordane, dieldrin, hexachlorobenzene,
hexachlorocyclohexanes, and trans-nonachlor [26]. Due
to their persistence in the environment and evidence of
health effects, the EPA has restricted or cancelled the
use of many OC pesticides [26]. Additionally, the
Stockholm Convention eliminated or restricted the use
of many OC pesticides throughout the world in 2004
[25]. However, these compounds continue to persist in
the environment and DDT is still in use in malariaafflicted areas. Thus, exposure to OC pesticides can
occur through consumption of contaminated food, water
and breastmilk; presence during application or manufacture; and touching or ingesting contaminated soil [35,
36]. Hexachlorocyclohexanes, hexachlorobenzene, heptachlor, DDT, and dichlorodiphenyldichloroethylene
(DDE)—a metabolite of DDT—are classified by the EPA
as probable human carcinogenic agents [37–40]. One
prior study using NHANES data to assess the association between OC pesticide exposures and mortality in
the general population found no significant overall association [34]. However, this study was limited by a relatively short follow-up time and the omission of
education or other measures of socioeconomic status as
covariates [41].
Given the sparsity of data on the associations between
POPs and mortality, our objective was to determine if
higher exposure to POPs—including individual PFASs,
OC pesticides, and individual or summary measures of
non-dioxin-like PCBs, dioxin-like PCBs, and PBDEs—are associated with greater risk of mortality in persons aged 60 years and older. We hypothesized that
higher exposure to POPs increases the risk of mortality
in persons aged 60 years and older.
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Methods
Study population

NHANES is conducted by the National Center for
Health Statistics (NCHS) to evaluate the health and nutritional status of adults and children in the United
States. NHANES represents all noninstitutionalized civilians living within the United States and utilizes a complex, four-stage sample design [42]. Annually, NHANES
collects data from approximately 5000 participants; data
collected includes household interviews, physical examinations, and biological specimens for laboratory tests
[42]. The laboratory tests are conducted on smaller, nationally representative subsamples of individuals from
the total examined study population to reduce respondent burden and aid in the completion of exams [43]. The
subsamples that are used for laboratory tests maintain
the representative design of the survey because the subsamples are chosen at random [43]. Additional details
are publicly available at: www.cdc.gov/nchs/nhanes. Our
study used NHANES data for the survey periods of
1999–2006 to determine exposure levels and status of
covariates. Different POPs were measured in different
subsamples of survey cycles. Therefore, our study used
data from 4 different subsamples with POPs measurements: OC pesticides from the 1999–2004 cycles, PBDEs
and PCBs from the 2003–2004 cycle, and PFASs from
the 2003–2006 cycles.
Measurement of POP concentrations

The NHANES laboratory measured PBDE analytes in
serum by performing solid phase extraction and isotope
dilution gas chromatography high-resolution mass spectrometry (GC/IDHRMS), while PCB and OC pesticide
analytes in serum were measured by high-resolution gas
chromatography/isotope-dilution high-resolution mass
spectrometry (HRGC/ID-HRMS); PFAS analytes were
measured by using solid phase extraction-high performance liquid chromatography-turboionspray ionizationtandem mass spectrometry (SPE-HPLC-TCI-MS/MS).
Details of the laboratory methods are publicly available
at: https://wwwn.cdc.gov/nchs/nhanes/. We used the
value of limit of detection (LOD)/√2 for all analyte measures that resulted in report of concentrations below the
LOD. Additionally, we used the lipid-adjusted concentrations for analyses of PBDEs, OC pesticides, and PCBs
in our primary analyses. To address the possibility of potentially influential outliers in our relatively small samples, we natural log transformed each exposure to
normalize the distribution. We then applied the Extreme
Studentized Deviate Multiple Outlier Procedure to identify and exclude outliers a priori [44]. This process resulted in the identification and exclusion of 11
observations from perfluorooctanoic acid (PFOA) measures, 7 from perfluorooctane sulfonic acid (PFOS)
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measures, 2 from trans-nonachlor measures, 5 from
p,p’-DDE measures, 4 from oxychlordane measures, and
3 from β-hexachlorocyclohexane measures. After outlier
removal, we standardized all analyte concentrations by
subtracting the sample mean and dividing by the standard deviation.
Mortality outcomes

We determined mortality status using the NCHS 2011
Public-use Linked Mortality Files. The length of followup time for each participant was determined using the
NHANES study examination date and date of death, if
dead, or end of follow-up, December 31, 2011. The
cause of death coding follows the 10th revision of the
International Statistical Classification of Diseases (ICD10) [45]. For analyses, we categorized mortality as either
all-cause, cancer (ICD codes: C00-C97), heart or cerebrovascular diseases (CBVD) (ICD codes: I00-I09, I11,
I13, I20-I51, I60-I69), or other-cause (non-cancer, nonheart/cerebrovascular disease) [45].
Statistical analyses

We included participants in our analysis if they were
60 years of age or older at the time of the NHANES
interview. We excluded participants from analysis if all
exposure analyte measurements were missing or if they
were missing data on any of the following covariates included in our primary analyses: age, gender, race/ethnicity, education, or smoking status. Given the larger
number of participants missing values for body mass
index (BMI), family poverty income ratio (PIR), or alcohol consumption, we filled in missing values using mode
single imputation for these three covariates, which are
used in sensitivity analyses.
For PBDEs, we excluded a total of 52 participants
(9.6%) for missing all PBDE analyte measures. We excluded an additional 4 (0.07%) participants for missing
covariate data; thus, we included a total of 483 PBDE
observations for analysis. Out of a total of 11 PBDE analytes, we analyzed the association between PBDE concentrations and mortality only for the 4 analytes that
were above the LOD in greater than 90% of the sample:
2,2′,4,4′,5,5′-hexabromodiphenyl ether (PBDE-153);
2,2′,4,4′,6-pentabromodiphenyl
ether
(PBDE-100);
2,2′,4,4′-tetrabromodiphenyl ether (PBDE-47); and
2,2′,4,4′,5,5′-hexabromobiphenyl (PBB-153). Additionally, we created summary measures of all PBDE concentrations (ng/g), as well as a sum for the 4 PDBE analytes
(ng/g) detectable in >90% of the sample by summing the
concentrations for the observations that had all PDBE
analyte data available (i.e., participants with measurements below LOD were included, however those with
no measurement data reported were excluded).
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For PFASs, we excluded a total of 71 participants
(6.4%) for missing all PFAS analyte measures; we removed an additional 4 participants (0.4%) from analysis
due to missing covariate data. After exclusions, there
was a total of 1043 observations for PFAS analyte analysis. Out of the 12 PFAS analytes, we analyzed associations between PFAS concentrations and mortality for
those 4 individual PFASs detected in greater than 90% of
the population: PFOA, PFOS, perfluorohexane sulfonic
acid (PFHxS), and perfluorononanoic acid (PFNA).
We excluded 94 participants (16.8%) for missing all
PCB analyte measures; we excluded an additional 3 observations (0.5%) due to covariate data missing. The
resulting population used for analysis included 461 observations. Instead of analyzing the individual PCB analytes (29 dioxin-like and 26 non-dioxin-like), we
considered six summary measures: (1) exposure to all
dioxin-like PCBs, (2) exposure to dioxin-like PCBs with
concentrations above the LOD in more than 90% of the
population, (3) exposure to all non-dioxin-like PCBs, (4)
exposure to non-dioxin-like PCB concentrations above
the LOD in more than 90% of the population, (5) toxicity of exposure to dioxin-like PCBs based on toxic
equivalency values (TEQs), and (6) toxicity of exposure
to dioxin-like PCBs measured above the LOD in greater
than 90% of the population based on TEQs. Similar to
the PBDE summary measures, participants with measurements below LOD were included; however, those
with no measurement data on any component PCB were
excluded. For dioxin-like PCBs, TEQs were calculated
using the 2005 WHO toxic equivalency factors (TEFs)
[46]. The serum concentrations of the dioxin-like PCBs
were multiplied by their respective TEF and then
summed.
For OC pesticides, we excluded a total of 107 participants (6.9%) because all analyte data was missing. We
removed an additional 6 participants (0.4%) due to missing covariate resulting in 1428 eligible participants. Out
of a total of 13 OC pesticide analytes, only those 4 with
measurements above the LOD in greater than 90% of
the population were considered for analyses for associations with mortality: Trans-nonachlor; p,p’-DDE; Oxychlordane; and β-hexachlorocyclohexane.
We assessed the associations between the analyte exposures described above and mortality by using Cox
proportional hazard models. We considered the complex
survey design in analyses by using the appropriate subsample weights, stratum, and primary sampling units per
NHANES recommendation. For our primary analyses,
we adjusted for age, gender, race/ethnicity, education
and smoking. In sensitivity analyses we also considered
two additional levels of adjustment: age-adjusted and adjusted for all the covariates in our primary model plus
BMI, PIR, and alcohol use. Additionally, we conducted
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sensitivity analyses: (1) omitting survey weighting, (2)
adjusting for lipids rather than using lipid-adjusted analyte value, and (3) including previously excluded potential outliers.
We also conducted exploratory analyses considering
effect modification by sex (male/female), BMI (<25/
≥25 kg/m2), smoking status (yes/no), and urine albumin
creatinine ratio (ACR) (<30/≥30 mg/g) using a multiplicative interaction term where our primary analyses
suggested presence of an association. In addition, given
PBDEs and OC pesticides were analyzed in the same 1/
3rd subsample in the 2003–2004 NHANES cycle, we
also conducted exploratory analyses in the ~450 individuals with both measures to determine whether PBDEs
and OC pesticide exposures had synergistic impact on
mortality. Specifically, we dichotomized exposures for
both PBDEs and each OC pesticide at the median and
included both terms and their multiplicative interaction
in a single model. (We were not able to conduct this
analysis with combinations including PFASs or PCBS
given their concentrations were measured in different
subsamples.) All analyses were performed using SAS version 9.4.
Human subjects protection issues

NHANES data were previously collected with the approval of the NCHS Research Ethics Review Board and
anonymized before release to the public. All participants
provided informed consent [42].

Results
Among the 483 participants included for PBDE analyses,
a total of 25.7% died during the follow-up; 7.1% were determined to be due to heart/cerebrovascular diseases,
6.7% due to cancer, and 11.9% due to other-causes
(Table 1). In the PBDE sample, the median age at time
of examination was 70.4 years and the majority of subjects were non-Hispanic white (82.2%). Slightly less than
half were male (43.6%) and had some college education
or above (47.1%), while slightly more than half smoked
(55.5%), consumed alcohol (58.6%), or had a family PIR
greater than 2.00 (61.7%). The mean measure for BMI at
time of examination was 28.0 kg/m2. The median
follow-up time was 6.4 years (minimum: 0.08 years,
maximum: 8.9 years). The characteristics of the 1043
subjects used in analyses for PFASs, 461 for PCBs, and
1428 for OC pesticides were similar, with the exception
of follow-up time and cumulative mortality, which varied
based on which NHANES cycles had POPs measurements (Table 1). Unweighted characteristics of the study
sample are available in Additional file 1: Table S1.
Table 2 shows the mean serum measurements for the
analyte measures used for analyses and Additional file 1:
Tables S2 to S5 summarize correlations between analytes
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Table 1 Characteristics and outcome of adults participating in the 1999–2006 NHANES by POPs analyte sample
PBDEs (N = 483)
NHANES 2003–2004

PFASs (N = 1043)
NHANES 2003–2006

PCBs (N = 461)
NHANES 2003–2004

OC pesticides (N = 1428)
NHANES 1999–2004

Estimatea

Estimatea

Estimatea

Estimatea

Std. Error of
Estimatea

Std. Error of
Estimatea

Std. Error of
Estimatea

Std. Error of
Estimatea

Age (years), medianb

70.4

0.3

71.0

0.3

70.2

0.4

70.5

0.2

Body mass index (kg/m2), mean

28.0

0.2

28.2

0.2

28.2

0.3

28.0

0.2

Follow-Up Time (years), median

6.4

0.2

5.5

0.1

7.4

0.1

8.7

0.2

Gender, % Male

43.6%

2.1

44.5%

2.0

42.8%

2.5

43.5%

1.2

82.2%

2.2

82.6%

2.1

82.8%

4

81.9%

1.6

Ethnicity, %
White, Non-Hispanic
Hispanic

5.3%

2.3

5.1%

1.1

5%

1.9

6.8%

1.5

Black, Non-Hispanic

7.6%

1.3

8%

1.1

8.5%

2.6

8.2%

1.1

Other

4.9%

1.2

4.3%

0.9

3.7%

1.2

3.2%

0.6

Family Poverty Income Ratio, %
Less than/equal 2

38.3%

2.7

42.7%

2.8

43.7%

4.3

46.3%

1.9

Greater than 2

61.7%

2.7

57.3%

2.8

56.3%

4.3

53.7%

1.9

25.8%

3.8

27.3%

2.3

30.9%

4.0

30.1%

1.7

Education Level, %
High school or less
High school graduate/GED

27.2%

2.4

31.0%

2.1

26.3%

2.4

27.7%

1.6

Some college or above

47.1%

4.9

41.7%

1.7

42.8%

3.9

42.2%

1.9

Smoker, % Yes

55.5%

2.2

54.5%

1.7

57.5%

3.9

55.3%

1.5

Consume Alcohol, % Yes

58.6%

4.0

65.9%

1.9

56.9%

6.2

61.7%

2.2

1.8

22.2%

1.5

23.0%

2.6

34.2%

1.4

Mortality Status During Follow-Up, % Deceased
All-cause

25.7%

Heart/cerebrovascular diseases

7.1%

1.1

5.7%

0.6

7.0%

1.0

7.9%

0.7

Cancer

6.7%

1.0

4.5%

0.7

4.8%

1.5

7.9%

0.8

Other-cause

11.9%

1.9

12.0%

1.5

11.2%

1.9

18.2%

1.4

Notes: OC, organochlorine; PBDEs, polybrominated diphenyl ethers; PCBs, polychlorinated biphenyls; PFASs, per- and polyfluoroalkyl substances; POPs, persistent
organic pollutants
a
Weighted to consider complex survey design
b
Adults 60 years or older included in study; individuals aged 85 and over were re-coded by NHANES to 85 years of age

of a given POP class. Four PBDE analytes were detected
above the LOD in greater than 90% of the cohort population: PBDE-153, PBDE-100, PBDE-47, and PBB-153.
The two PBDE summary measures (total PBDEs and
PBDEs above LOD in >90% of the sample) were highly
correlated (r = 0.99, p < 0.0001). Four PFAS analytes
were above the LOD in greater than 90% of the participants: PFOA, PFOS, PFHxS, and PFNA. PFAS analytes
were not strongly correlated; correlation coefficients
ranged from 0.22 (p < 0.0001) to 0.63 (p < 0.0001). For
PCBs, correlations between each of the summary measures considering all PCBs of a given type and the corresponding summaries restricted to those detected in
>90% of the sample were high (r = 0.97 or higher, all
p < 0.0001). The correlations between all dioxin-like
PCBs and non-dioxin-like PCBs were lower than PBDE
summaries with r = 0.80 (p < 0.0001). A total of 4 OC
pesticide analytes were above the LOD in greater than

90% of the study group: β-hexachlorocyclohexane; p,p’DDE; Oxychlordane; and Trans-nonachlor. Notably, of
the OC pesticides, p,p’-DDE, had a much higher mean
serum concentration compared to any other analyte.
The correlations between OC pesticides ranged from
0.07 (p = 0.007) to 0.86 (p < 0.0001).
Table 3 summarizes the association between a one
standard deviation unit increase in serum measurements
and all-cause mortality, adjusting for age, gender, race/
ethnicity, education, and smoking status. Higher exposure to PBDE-153 was associated with increased risk of
all-cause mortality (HR: 1.07 per 1 SD unit increase in
lipid-adjusted serum concentrations, 95% CI: 1.00, 1.14).
There was little evidence to support associations between
PFASs, PCBs, and the other PBDE measures with allcause mortality. While the OC pesticides appeared to be
associated with increased risk of all-cause mortality, only
the association between β-hexachlorocyclohexane and all-
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Table 2 Serum concentrations of analyzed POPs in adults 60 years or older
Exposure Measure

N

Mediana

Std. Error of Median a

436

53.5

4.1

PBDEs (ng/g of lipid)
Σ PBDEs
Σ PBDEs above LOD in >90%

473

42.5

3.7

2,2′,4,4′,5,5′-hexabromodiphenyl ether (PBDE-153)

483

5.1

0.4

2,2′,4,4′,6-pentabromodiphenyl ether (PBDE-100)

483

3.6

0.3

2,2′,4,4′-tetrabromodiphenyl ether (PBDE-47)

474

19.7

2.0

2,2′,4,4′,5,5′-hexabromobiphenyl (PBB-153)

481

4.4

0.7

Perfluorooctanoic acid (PFOA)

1036

23.7

0.7

Perfluorooctane sulfonic acid (PFOS)

1032

4.3

0.2

Perfluorohexane sulfonic acid (PFHxS)

1043

2.0

0.1

Perfluorononanoic acid (PFNA)

1043

1.0

0.07

Σ Dioxin-like PCBs

380

57.5

2.5

Σ Dioxin-like PCBs above LOD in >90%

414

58.0

2.4

Σ Non-dioxin-like PCBs

405

284.3

10.1

Σ Non-dioxin-like PCBs above LOD in >90%

413

281.7

10.4

Σ TEQ Dioxin-like PCBs

385

0.03

0.001

Σ TEQ Dioxin-like PCBs above LOD in >90%

420

0.01

0.001

β-hexachlorocyclohexane

1397

25.1

1.1

p,p’-DDE

1411

666.1

33.0

Oxychlordane

1312

29.0

0.9

Trans-nonachlor

1404

44.8

1.7

PFASs (ng/g)

PCBs (ng/g of lipid)

OC Pesticides (ng/g of lipid)

Notes: DDE, dichlorodiphenyldichloroethylene; LOD, limit of detection; OC, organochlorine; PBDEs, polybrominated diphenyl ethers; PCBs, polychlorinated
biphenyls; PFASs, per- and polyfluoroalkyl substances; POPs, persistent organic pollutants; TEQ, toxic equivalency values
a
weighted to consider complex survey design

cause mortality achieved statistical significance (HR:1.18
per 1 SD unit increase in lipid-adjusted serum concentrations 95%CI:1.01, 1.38). Exposure to PBDEs, PFASs, and
PCBs were not associated with cause-specific mortality
(Additional file 1: Tables S6-S8); however, higher exposure to all 4 OC pesticides was associated with increased risk of other-cause, but not cardiovascular or
cancer mortality (Fig. 1, Additional file 1: Table S9).
The results were materially unchanged with additional
adjustment (Additional file 1: Tables S6-S9) and
across all sensitivity analyses (Additional file 1: Tables
S10-S13), with the exception that we no longer see an
association between β-hexachlorocyclohexane and either all-cause or other-cause mortality in sensitivity
analyses when we do not exclude potentially influential outliers.
As we observed statistically significant main effects for
β-hexachlorocyclohexane with all-cause mortality and all
four OC pesticide analytes with other-cause mortality,
we proceeded to explore whether sex, BMI, smoking

status, or ACR modified these associations; results are
summarized in Table 4. Associations were uniformly
stronger among overweight individuals, although there
was little statistical support for effect modification with
the exception of the association between oxychlordane
and other-cause mortality (p = 0.04). There was little
evidence of effect modification by smoking status or
ACR. Finally, the association between OC exposure and
other-cause mortality was stronger in men for transnonachlor, p,p’-DDE, and oxychlordane, but was stronger
in women for β-hexachlorocyclohexane. However, there
was no support for effect modification by sex when considering the association between β-hexachlorocyclohexane
and all-cause mortality.
In exploratory analyses, there was little evidence of interaction between PBDEs and OC pesticide exposure on cancer or cardiovascular/cerebrovascular mortality. However,
we did observe a marginally significant interaction between
PBDEs with p,p’-DDE and oxychlordane whereby those
with high exposure to both PBDEs and either OC pesticide
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Table 3 Associations between a one standard deviation unit increase in serum POP measures and all-cause mortality
Exposure

N

Hazard Ratio (95% CI)a

p-valuea

436

1.07 (0.90, 1.27)

0.42

PBDEs (ng/g of lipid)
Σ PBDEs
Σ PBDEs above LOD in >90%

473

1.10 (0.93, 1.30)

0.24

2,2′,4,4′,5,5′-hexabromodiphenyl ether (PBDE-153)

483

1.07 (1.00, 1.14)

0.06

2,2′,4,4′,6-pentabromodiphenyl ether (PBDE-100)

483

1.05 (0.91, 1.23)

0.47

2,2′,4,4′-tetrabromodiphenyl ether (PBDE-47)

474

1.10 (0.91, 1.33)

0.29

2,2′,4,4′,5,5′-hexabromobiphenyl (PBB-153)

482

1.04 (0.89, 1.21)

0.63

PFASs (ng/g)
Perfluorooctane sulfonic acid (PFOS)

1036

0.91 (0.80, 1.03)

0.12

Perfluorooctanoic acid (PFOA)

1032

0.93 (0.82, 1.06)

0.27

Perfluorononanoic acid (PFNA)

1043

0.92 (0.80, 1.07)

0.26

Perfluorohexane sulfonic acid (PFHxS)

1043

0.88 (0.72, 1.08)

0.21

380

0.94 (0.74, 1.18)

0.55

PCBs (ng/g of lipid)
Σ Dioxin-like PCBs
Σ Dioxin-like PCBs above LOD in >90%

414

0.91 (0.77, 1.08)

0.27

Σ Non-dioxin-like PCBs

405

0.94 (0.72, 1.22)

0.61

Σ Non-dioxin-like PCBs above LOD in >90%

413

0.97 (0.76, 1.24)

0.81

Σ TEQ Dioxin-like PCBs

385

1.01 (0.78, 1.31)

0.92

Σ TEQ Dioxin-like PCBs above LOD in >90%

420

0.99 (0.80, 1.23)

0.92

OC Pesticides (ng/g of lipid)
Trans-nonachlor

1404

1.05 (0.98, 1.12)

0.17

p,p’-DDE

1411

1.07 (0.99, 1.16)

0.09

Oxychlordane

1312

1.07 (1.00, 1.14)

0.07

β-hexachlorocyclohexane

1397

1.18 (1.01, 1.38)

0.04

Notes: CI, confidence interval; DDE, dichlorodiphenyldichloroethylene; LOD, limit of detection; OC, organochlorine; PBDEs, polybrominated diphenyl ethers; PCBs,
polychlorinated biphenyls; PFASs, per- and polyfluoroalkyl substances; POPs, persistent organic pollutants; TEQ, toxic equivalency values
a
Adjusted for age, gender, race/ethnicity, education, and smoking status; materially unchanged with additional adjustment for alcohol consumption, BMI, and
poverty income ratio

had higher than expected other-cause mortality (Table 5).
While similar trends were observed for trans-nonachlor or
β-hexachlorocyclohexane there was little statistical support
for effect modification in these analyses. While we observed
statistically significant p-values for the interaction of PBDEs
with p,p’-DDE, the pattern of association observed for allcause mortality was not repeated. There was no statistical
support for interaction with the other OC pesticides on
other-cause mortality. Of note, our category-specific estimates are often imprecise given small numbers.

Discussion
Our study found that serum measurements of PBDEs,
PFASs, and PCBs are not clearly associated with increased mortality in the U.S. population aged 60 years or
older. β-hexachlorocyclohexane, an OC pesticide, was
associated with an increased risk of all-cause mortality.
All four OC pesticides detectable in >90% of the sample
(oxychlordane; p,p’-DDE; Trans-nonachlor; and βhexachlorocyclohexane) were associated with increased

risk of other-cause (non-cancer, non-cardiovascular)
mortality. Exploratory analyses suggest these associations may be modified by sex, BMI, or PBDE exposures,
but this requires further confirmation in an independent
sample.
To our knowledge, this study was the first to examine
the effects of PBDE exposures on mortality in a human
sample. Prior studies of the associations between exposure to PFASs and mortality were conducted in occupational settings and report either no association or lower
mortality in workers exposed to PFASs [47–50]. Our results were similar; while our point estimates suggested
PFASs were associated with decreased mortality these
results were not statistically significant. Multiple prior
studies report elevated risk of cancer-related mortality
with PCB exposure in occupational and poisoning settings, although these results are not conclusive given
concerns about unclear dose-response relationships and
residual confounding [51–58]. Prior studies in NHANES
using summaries of PCB exposures from 1999 to 2004
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Fig. 1 Associationsa between a one standard deviation unit increase in serum OC pesticide measures and mortality. Note: CBVD, cerebrovascular
disease; DDE, dichlorodiphenyldichloroethylene; Heart, heart disease; OC, organochlorine. a Adjusted for age, gender, race/ethnicity, education,
and smoking status

report associations between total PCB exposures and excess cardiovascular mortality, but not all-cause or
cancer-related mortality, among adults 70 years or older
over a mean of 4.1 years of follow-up [41] and associations between higher exposure to dioxin-like compounds
and all-cause mortality in adults ages 40 or older over a
mean of 4.6 years of follow-up [33]. Our results conflict
with these prior findings as we found no association between PCBs and all-cause or cause-specific analyses and
may be related to lack of adjustment for education or
other measures of socioeconomic status, shorter followup time, and consideration of a smaller, different set of
compounds in prior studies. Finally, prior studies of occupational OC pesticide exposure and mortality generally report found lower than expected rates of all-cause
mortality in exposed persons, but likely suffer from
healthy-worker bias [59–61] A prior study using data
from NHANES reported no association between exposure to OC pesticides and all-cause mortality, cancer
mortality, or cardiovascular mortality over a mean
4.1 year follow-up period in persons 70 years and older
[41], but did not consider other-cause mortality. Thus,

our finding of increased risk of other-cause (non-cancer,
non-cardiovascular) mortality with greater exposure OC
pesticides is novel. Given the heterogeneous nature of
“other-cause” mortality and the wide-ranging causes of
death that are ultimately attributable to underlying diabetes or dementia, it is plausible that our results for OC
pesticide exposure and other-cause mortality is due to
associated increased risk of diabetes or dementia. Several
recent studies have linked OC pesticide exposure to incident diabetes or markers indicative of increased risk of
diabetes [62–64] as well as to elevated risk for cognitive
decline or dementia [65–67].
While our report of exploratory analyses considering
the combined impact of PBDEs and OC pesticides is
novel, several prior studies suggest modification of the
POPs-mortality association by BMI, smoking, or ACR.
While not statistically significantly in our analyses, the
suggestion of greater mortality among overweight and
obese individuals with high OC pesticide exposure is opposite than reported previously. [41, 68] Conversely, while
we did not observe significant effect modification by ACR,
our point estimates were often consistent with the prior
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Table 4 Summary of exploratory analyses considering effect modification by BMI, smoking status, and sex where main effects were present
Mortality/Exposure

Hazard Ratio (95% CI)a

N

p-value for interaction

Hazard Ratio (95% CI)a

p-value for interaction

BMI < 25

BMI ≥ 25

1397

1.06 (0.82, 1.37)

1.36 (1.15, 1.62)

0.08

1.15 (0.98, 1.34)

1.36 (1.02, 1.8)

0.24

Trans-nonachlor

1404

1.07 (0.98, 1.17)

1.15 (1.06, 1.26)

0.18

1.1 (1.04, 1.16)

1.14 (0.98, 1.33)

0.59

p,p’-DDE

1411

1.05 (0.74, 1.47)

1.13 (1.05, 1.22)

0.64

1.15 (1.05, 1.25)

1.03 (0.82, 1.3)

0.39

Oxychlordane

1312

1.09 (0.99, 1.2)

1.25 (1.12, 1.4)

0.04

1.12 (1.04, 1.2)

1.27 (1.07, 1.51)

0.12

β-hexachlorocyclohexane

1397

1.21 (0.96, 1.53)

1.35 (1.12, 1.63)

0.38

1.25 (1.02, 1.54)

1.3 (0.85, 1.98)

0.87

Non-Smoker

Current Smoker

All-Cause
β-hexachlorocyclohexane
Other-cause

Mortality/Exposure

Hazard Ratio (95% CI)a

N

Hazard Ratio (95% CI)a

p-value for interaction

p-value for interaction

ACR < 30

ACR ≥ 30

0.71

1.16 (0.98, 1.39)

1.35 (1.08, 1.68)

0.30

1.19 (1.07, 1.33)

0.07

1.08 (1, 1.17)

1.18 (1.01, 1.37)

0.28

1.38 (1.13, 1.69)

0.01

1.1 (0.97, 1.24)

1.17 (0.98, 1.39)

0.52

1.11 (1.02, 1.19)

1.37 (1.1, 1.7)

0.05

1.13 (1.04, 1.22)

1.18 (0.98, 1.41)

0.64

1.46 (1.15, 1.85)

1.11 (0.89, 1.39)

0.05

1.26 (1.01, 1.56)

1.37 (0.96, 1.96)

0.67

Female

Male

1397

1.22 (0.97, 1.54)

1.16 (0.96, 1.4)

Trans-nonachlor

1404

1.07 (0.99, 1.15)

p,p’-DDE

1411

1.05 (0.9, 1.23)

Oxychlordane

1312

β-hexachlorocyclohexane

1397

All-Cause
β-hexachlorocyclohexane
Other-cause

a

Weighted to consider complex survey design, adjusted for age, gender, race/ethnicity, education, and smoking status

report of greater mortality among those with high ACR
and high OC pesticide exposure [69] or among current
smokers with high OC pesticide exposure [70]. The suggestion that sex modifies the OC pesticide other-cause
mortality association is potentially plausible given potential endocrine-disruption related effects of exposure [71],
but requires further confirmation in other samples.
There are limitations to our study. First, our sample
size for each analysis was relatively small, due to data
availability or concerns about combining multiple years
of exposure data in the face of changing lists of analytes
assessed in different cycles and potential time trends in
exposure. This limited our ability to detect small effect
and our ability to further investigate the association with
more refined cause-specific mortality categories.

Similarly, although motivated by evidence of effect modification in other settings [34, 68–70], we consider our analyses of effect modification to be exploratory given our
small sample. Future work in larger samples will be required to examine the effect of exposure within potentially
susceptible sub-populations. We also view our analyses of
the combined effect of PBDEs and OC pesticides to be exploratory, and were unable to consider combined effects of
multiple classes of POPs, as PCBs, PFASs, and PBDEs/OC
pesticidess were measured in different subsamples. As with
any epidemiologic study, we cannot definitively rule out the
possibility of bias or chance. However, we adjusted our analyses for many possible confounders, minimizing the potential for residual confounding. We used a nationallyrepresentative sample and evaluated associations with

Table 5 Summary of exploratory analyses considering synergism of exposure to PBDEs and OC pesticides on all-cause and other-cause
mortality
HR (95%CI)a, all-cause mortality
Σ PBDEs above LOD in >90%

Trans-nonachlor

p,p’-DDE

Oxychlordane

β-hexachlorocyclohexane
a

HR (95%CI)a, other-cause mortality
Σ PBDEs above LOD in >90%

Less than median

Higher than median

interaction
p-value

Less than median

Higher than median

interaction
p-value

Less than median

1.0 (Ref.)

1.08 (0.58, 2.00)

0.09

1.0 (Ref.)

0.47 (0.12, 1.86)

0.24

Higher than median

1.07 (0.67, 1.70)

1.96 (1.11, 3.43)

0.95 (0.47, 1.94)

1.00 (0.52, 1.93)

Less than median

1.0 (Ref.)

1.10 (0.63, 1.94)

Higher than median

0.84 (0.46, 1.54)

1.63 (1.03, 2.59)

Less than median

1.0 (Ref.)

0.90 (0.40, 2.04)

Higher than median

0.87 (0.50, 1.51)

1.60 (1.00, 2.54)

Less than median

1.0 (Ref.)

1.13 (0.61, 2.10)

Higher than median

0.78 (0.41, 1.48)

1.43 (0.86, 2.74)

Adjusted for age, gender, race/ethnicity, education, and smoking status

0.08

0.14

0.26

1.0 (Ref.)

0.37 (0.17, 0.81)

0.93 (0.42, 2.08)

1.06 (0.46, 2.42)

1.0 (Ref.)

0.88 (0.39, 1.97)

0.34 (0.05, 2.49)

0.96 (0.54, 1.70)

1.0 (Ref.)

0.60 (0.17, 2.1)

0.78 (0.36, 1.70)

0.76 (0.37, 1.54)

0.01

0.29

0.49
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mortality, limiting the potential for selection bias. Finally, as
our exposure and outcome are objective outcomes, and
mortality was assessed independently of exposure status,
we expect minimal impact of measurement error and that
any resulting bias would be towards the null.
Our study also has strengths. The data is from NHANES
and is a nationally representative study [42], thus our findings are generalizable to the older U.S. population as a
whole. Several aspects of our primary analyses were novel,
including examination of the association of PBDEs with
mortality and consideration of associations between POPs
and non-CVD, non-cancer mortality. We were able to address several of the potential limitations of the previous literature, including addressing potential confounding by
education and socioeconomic status. Additionally, our
study benefited from relatively long follow-up times, ranging from 9 to 13 years, which minimizes the potential impact of reverse causation, whereby impending death
impacts POPs exposure levels.

Conclusions
Our study provides evidence of an adverse association between exposure to OC pesticides and non-cancer, nonheart/cerebrovascular disease mortality in adults 60 years or
older in the U.S. This association may be modified by several
factors, including exposure to other POPs. Additional research to confirm this finding and determine how OC pesticides may impact other-cause mortality is warranted.
Additional file
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sample. Tables S2-S5. Correlation coefficients between within-class POP
analytes. Tables S6-S9. Associations between a one standard deviation unit
increase in serum POP measures and all-cause, cancer, heart/cerebrovascular
diseases, and other-cause mortality with varying levels of adjustment.
Tables S10-S13. Sensitivity analyses for associations between a one
standard deviation unit increase in serum POP measures and all-cause, cancer,
heart/cerebrovascular diseases, and other-cause mortality. (DOCX 79 kb)
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